274 related articles for article (PubMed ID: 23490328)
1. Penetration of a topically administered anti-tumor necrosis factor alpha antibody fragment into the anterior chamber of the human eye.
Thiel MA; Wild A; Schmid MK; Job O; Bochmann F; Loukopoulos V; Alcantara W; Schmidt A; Lichtlen P; Escher D
Ophthalmology; 2013 Jul; 120(7):1403-8. PubMed ID: 23490328
[TBL] [Abstract][Full Text] [Related]
2. Efficient intraocular penetration of topical anti-TNF-alpha single-chain antibody (ESBA105) to anterior and posterior segment without penetration enhancer.
Ottiger M; Thiel MA; Feige U; Lichtlen P; Urech DM
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):779-86. PubMed ID: 18757511
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye.
Furrer E; Berdugo M; Stella C; Behar-Cohen F; Gurny R; Feige U; Lichtlen P; Urech DM
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):771-8. PubMed ID: 18757508
[TBL] [Abstract][Full Text] [Related]
4. Fourth-generation fluoroquinolone penetration into the aqueous humor in humans.
McCulley JP; Caudle D; Aronowicz JD; Shine WE
Ophthalmology; 2006 Jun; 113(6):955-9. PubMed ID: 16603244
[TBL] [Abstract][Full Text] [Related]
5. Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients.
Kim DH; Stark WJ; O'Brien TP; Dick JD
Ophthalmology; 2005 Nov; 112(11):1992-6. PubMed ID: 16183125
[TBL] [Abstract][Full Text] [Related]
6. Penetration of topically applied ciprofloxacin and ofloxacin into the aqueous humor and vitreous.
Yalvac IS; Basci NE; Bozkurt A; Duman S
J Cataract Refract Surg; 2003 Mar; 29(3):487-91. PubMed ID: 12663011
[TBL] [Abstract][Full Text] [Related]
7. Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor.
Solomon R; Donnenfeld ED; Perry HD; Snyder RW; Nedrud C; Stein J; Bloom A
Ophthalmology; 2005 Mar; 112(3):466-9. PubMed ID: 15745775
[TBL] [Abstract][Full Text] [Related]
8. Penetration of topically applied ciprofloxacin, norfloxacin and ofloxacin into the aqueous humor of the uninflamed human eye.
Akkan AG; Mutlu I; Ozyazgan S; Gok A; Yigit U; Ozuner Z; Senses V; Pekel H
J Chemother; 1997 Aug; 9(4):257-62. PubMed ID: 9269605
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple-masked trial. Part 1: aqueous concentration of moxifloxacin.
Vasavada AR; Gajjar D; Raj SM; Vasavada V; Vasavada V
J Cataract Refract Surg; 2008 Aug; 34(8):1379-82. PubMed ID: 18655991
[TBL] [Abstract][Full Text] [Related]
10. Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous.
Hariprasad SM; Blinder KJ; Shah GK; Apte RS; Rosenblatt B; Holekamp NM; Thomas MA; Mieler WF; Chi J; Prince RA
Arch Ophthalmol; 2005 Jan; 123(1):39-44. PubMed ID: 15642810
[TBL] [Abstract][Full Text] [Related]
11. Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration.
Hariprasad SM; Mieler WE; Shah GK; Blinder KJ; Apte RS; Holekamp NM; Thomas MA; Chi J; Prince RA
Trans Am Ophthalmol Soc; 2004; 102():149-55; discussion 155-7. PubMed ID: 15747753
[TBL] [Abstract][Full Text] [Related]
12. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given by different methods before cataract surgery.
Ong-Tone L
J Cataract Refract Surg; 2007 Jan; 33(1):59-62. PubMed ID: 17189794
[TBL] [Abstract][Full Text] [Related]
13. Corneal penetration of fluoroquinolones: aqueous humor concentrations after topical application of levofloxacin 0.5% and ofloxacin 0.3% eyedrops.
Koch HR; Kulus SC; Roessler M; Ropo A; Geldsetzer K
J Cataract Refract Surg; 2005 Jul; 31(7):1377-85. PubMed ID: 16105610
[TBL] [Abstract][Full Text] [Related]
14. Aqueous prostaglandin E(2) of cataract patients at trough ketorolac and bromfenac levels after 2 days dosing.
Bucci FA; Waterbury LD
Adv Ther; 2009 Jun; 26(6):645-50. PubMed ID: 19568702
[TBL] [Abstract][Full Text] [Related]
15. Differential aqueous and vitreous concentrations of moxifloxacin and ofloxacin after topical administration one hour before vitrectomy.
Lai WW; Chu KO; Chan KP; Choy KW; Wang CC; Tsang CW; Pang CP
Am J Ophthalmol; 2007 Aug; 144(2):315-8. PubMed ID: 17659971
[TBL] [Abstract][Full Text] [Related]
16. Aqueous penetration of moxifloxacin 0.5% ophthalmic solution and besifloxacin 0.6% ophthalmic suspension in cataract surgery patients.
Yoshida J; Kim A; Pratzer KA; Stark WJ
J Cataract Refract Surg; 2010 Sep; 36(9):1499-502. PubMed ID: 20692561
[TBL] [Abstract][Full Text] [Related]
17. Aqueous and vitreous penetration of linezolid (Zyvox) after oral administration.
Fiscella RG; Lai WW; Buerk B; Khan M; Rodvold KA; Pulido JS; Labib S; Shapiro MJ; Blair NP
Ophthalmology; 2004 Jun; 111(6):1191-5. PubMed ID: 15177970
[TBL] [Abstract][Full Text] [Related]
18. Ocular penetration of topical antibiotics: study on the penetration of chloramphenicol, tobramycin and netilmicin into the anterior chamber after topical administration.
Cagini C; Piccinelli F; Lupidi M; Messina M; Cerquaglia A; Manes S; Fiore T; Pellegrino RM
Clin Exp Ophthalmol; 2013; 41(7):644-7. PubMed ID: 23433257
[TBL] [Abstract][Full Text] [Related]
19. Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device.
Hariprasad SM; Shah GK; Chi J; Prince RA
J Cataract Refract Surg; 2005 Nov; 31(11):2142-6. PubMed ID: 16412929
[TBL] [Abstract][Full Text] [Related]
20. [Intraocular penetration of ciprofloxacin after infusion and oral administration].
Mounier M; Adenis JP; Denis F
Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):724-7. PubMed ID: 3054755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
